Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734368 · ClinicalTrials.gov registry record
A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 53
- Enrollment target
NCT02734368: Clinical Trial study, sponsored by University of Pennsylvania.
NCT02734368 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734368 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the MRI characteristics of Chronic Obstructive Pulmonary Disease subjects both at baseline and yearly for a period of 5 years, and to correlate these biomarkers with pulmonary function tests, CT scan, 6 Minute-walk tests, and respiratory questionnaires. The central hypothesis is that quantitative assessment of the lung through magnetic resonance imaging of hyperpolarized 3He can detect early alterations in structure and function which are precursors to clinically apparent COPD and that these precursors can be used to predict progression of disease earlier and better than established clinical methods. Novel assessments using 3He MRI will lead to new information about COPD and will be critical for characterizing disease response to therapy. A secondary hypothesis is that a variety of technical improvements in the techniques of hyperpolarized gas MRI will accelerate the translation of this relatively new modality to clinical use.
Interventions
- DRUG Hyperpolarized Helium-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2010-02 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734368
The ClinicalTrials.gov registry entry for NCT02734368 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized Helium-3 is the first listed.
NCT02734368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02734368 about?
NCT02734368 is a clinical study titled "A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease". The purpose of this study is to determine the MRI characteristics of Chronic Obstructive Pulmonary Disease subjects both at baseline and yearly for a period of 5 years, and to correlate these biomarkers with pulmonary function tests, CT scan, 6 Minute-walk tests, and respiratory questionnaires. The...
What is the current status of trial NCT02734368?
This trial is currently terminated. The enrollment target is 53 participants. The study started on 2010-02. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02734368?
The interventions under investigation include: Hyperpolarized Helium-3 (DRUG).
Who is sponsoring clinical trial NCT02734368?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.